Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

TMSF vs AAL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AAL Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

AAL Overall Winner 6-Pillar Tally: TMSF 0 – 6 AAL Matrix Metrics: TMSF 1 – 9 AAL

As of Nov 16, 2026, American Airlines Group Inc. (AAL) is the stronger overall head-to-head candidate over TMSF (TMSF) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TMSF carries a Unified Composite Score of 43.9/100 (HOLD) at $48.88 (N/M Forward P/E, N/A operating margin), whereas AAL carries 53.4/100 (HOLD) at $13.24 (14.1x Forward P/E, 1.8% operating margin).

  • Technical & Structure Timing Caution: TMSF is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.3); meanwhile AAL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TMSF vs AAL
TMSF US Equity
TMSF
Institutional Equity
$48.88
-0.29% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.14β · 4% Vol
Unified Composite Score
43.9 / 100 HOLD
Tech 49.0 Fund 50.0 Flow 50.0 Mom 35.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.8%) with fading momentum, RSI 40
RSI-14: 40.3 · SMA20: $49.12 · SMA50: $49.15
AAL NASDAQ Head-to-Head Winner
American Airlines Group Inc.
Air Transportation, Scheduled
$13.24
+0.53% 1D
Market Cap $8.7B
TTM Revenue $61.0B
Forward P/E 14.1x
Beta / 30D Vol 1.86β · 53% Vol
Unified Composite Score
53.4 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.6 · SMA20: $12.98 · SMA50: $12.94

6-Pillar Scorecard Institutional Category Breakdown (TMSF 0 – 6 AAL)

Columns: Metric · TMSF · AAL
1. Valuation Multiples AAL
Forward P/E N/M 14.1x
Trailing P/E N/M 11.3x
PEG Ratio N/M 0.21x
EV / Revenue N/M 0.7x
2. Growth & Scale AAL
Revenue Growth (YoY) N/A +19.3%
Earnings Growth (YoY) N/A -88.2%
TTM Revenue (USD) N/A $61.0B
Market Cap N/A $8.7B
3. Profitability & Quality AAL
Gross Margin N/A 20.8%
Operating Margin N/A 1.8%
Net Profit Margin N/A -0.8%
Return on Equity (ROE) N/A 0.0%
4. Balance Sheet & Cash Flow AAL
Cash Generation (TTM) N/A -$91M
Cash Flow Margin N/A -0.1%
Net Cash / Leverage N/A ROE $36.1B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AAL
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 46.1% (16th %ile)
Put/Call OI Skew N/A 1.38x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Distribution DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat AAL
OpEx & R&D Intensity N/A 19.0% of Rev ($11.6B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Airlines Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TMSF (1) vs AAL (9)
Institutional Metric TMSF AAL Criterion Row Edge
Market Capitalization
Scale
N/A $8.7B Larger Scale AAL
Trailing P/E Ratio
Valuation
N/M 11.3x Lower Multiple AAL
Forward P/E Ratio
Valuation
N/M 14.1x Lower Multiple AAL
Revenue Growth (YoY)
Growth
N/A +19.3% Higher Growth AAL
Operating Margin (TTM)
Profitability
N/A 1.8% Higher Margin AAL
Net Profit Margin
Profitability
N/A -0.8% Higher Margin AAL
Return on Equity (ROE)
Capital Efficiency
N/A 0.0% Higher ROE AAL
52-Week Range Position
Momentum
17% ($48–$51) 36% ($10–$19) Stronger Trend AAL
Beta / 30D Volatility
Risk Regime
0.14β · 4% Vol 1.86β · 53% Vol Lower Realized Risk TMSF
Unified Institutional Score
Composite Signal
43.9 / 100 (HOLD) 53.4 / 100 (HOLD) Higher Composite AAL
Trailing 12M Revenue (USD)
Operating Scale
N/A $61.0B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 20.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.21x PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$91M ($36.1B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AAL +11.66 pp
TMSF: -0.21% · AAL: +11.45%
3M Horizon TMSF +3.19 pp
TMSF: -2.58% · AAL: -5.77%
6M Horizon AAL +9.19 pp
TMSF: -2.07% · AAL: +7.12%
1Y Horizon AAL +10.59 pp
TMSF: -2.42% · AAL: +8.17%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TMSF vs AAL. Trailing 12-month operating profitability (TMSF N/A vs AAL 1.8%) and valuation multiples (TMSF N/M vs AAL 14.1x Forward P/E) are benchmarked directly in Pillar 4 below.

TMSF ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
AAL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$61.0B
Gross Margin20.8%
Op. Margin1.8%
ROE / Fwd P/E0.0% · 14.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TMSF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TMSF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AAL CONSOLIDATION
101d in phase · OBV DISTRIBUTION
Current IV 46.1%
IV Percentile 16th %ile
Put/Call OI Skew 1.38x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact AAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TMSF Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AAL Moat Profile Cyclical / Execution-Driven Positioning
Airlines Operator
Competes within the Airlines value chain with $8.7B market capitalization and 1.8% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($11.6B)
90D Engineering Disclosures 0 Published

Investor FAQ TMSF vs AAL Key Questions & Quantitative Answers

As of Nov 16, 2026, American Airlines Group Inc. (AAL) is the stronger overall head-to-head candidate over TMSF (TMSF) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TMSF carries a Unified Composite Score of 43.9/100 (HOLD) at $48.88 (N/M Forward P/E, N/A operating margin), whereas AAL carries 53.4/100 (HOLD) at $13.24 (14.1x Forward P/E, 1.8% operating margin). Technical & Structure Timing Caution: TMSF is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.3); meanwhile AAL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AAL leads the Growth & Scale pillar: TMSF posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with AAL at +19.3% YoY revenue growth and -88.2% YoY earnings growth on $61.0B TTM revenue (20.8% gross margin, 1.8% operating margin). On trailing 12-month operating scale, TMSF generates N/A in USD-normalized revenue versus $61.0B for AAL. In operating R&D and SG&A reinvestment, TMSF deploys N/A (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($11.6B) (0 disclosures) for AAL.

AAL screens cheaper on headline valuation multiples. TMSF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AAL trades at 14.1x Forward P/E, 11.3x Trailing P/E, 0.21x PEG, and 0.7x EV/Revenue (-0.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TMSF (N/A ROE) versus AAL (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, TMSF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 4% Vol realized risk). By comparison, AAL carries 46.1% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.38x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.86β · 53% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.